New Brunswick cannabis users are being warned their Zenabis “light” CBD gel caps could pack an unexpected punch.
On Tuesday Health Canada issued a product recall for Zenabis Global, Inc. (TSX: ZENA) Namaste CBD light gel caps sold in New Brunswick because the pill bottles actually contained THC gel caps.
The 15 capsule bottles were mislabelled, the health authority reported, and instead of containing a light dose of 0.19 milligrams of THC and 6.13 milligrams of CBD per gel cap, they contained 2.25 milligrams of THC and no CBD.
Cannabidiol, or CBD, is a non-psychoactive compound in cannabis meaning it does not get users high and is often used for pain relief or relaxation. Tetrahydrocannabinol, better known as THC, is the other most common compound in cannabis and is responsible for the high users experience.
Read more: Cannabis cuts headache and migraine pain in half: study
Anyone using the recalled product would therefore get higher than they were expecting. Health Canada has not yet received any adverse reaction reports or complaints for the recalled product, according to Tuesday’s recall notice. Zenabis has heard one complaint, it said.
There were 165 units of the product sold on Oct. 7, 2019, from Cannabis NB, the province’s provincial retail chain.
Customers can return the recalled product to the retailer they bought it from, or, you know, try out some bonus THC gel caps.
Just remember Health Canada’s recommendation to start low and go slow.
michelle@mugglehead.com
@missmishelle
